A Phase 1b Trial of AR-42 With Pomalidomide in Relapsed Multiple Myeloma
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2017
At a glance
- Drugs AR 42 (Primary) ; Pomalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- 03 Jul 2017 Status changed from recruiting to suspended.
- 09 May 2016 Status changed from not yet recruiting to recruiting.
- 07 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.